Table 1 Patient characteristics
Variables | Total n = 59 | Fracking n = 30 | Balloon n = 29 | P-value |
|---|---|---|---|---|
Age, y | 77.0 ± 8.0 | 77.3 ± 8.4 | 76.7 ± 7.8 | 0.774 |
Men | 38 (64) | 23 (77) | 15 (52) | 0.046 |
Body mass index, kg/m2 | 22.0 ± 3.7 | 21.3 ± 2.9 | 22.8 ± 4.2 | 0.130 |
Current smoker | 12 (20) | 6 (20) | 6 (21) | 0.949 |
Hypertension | 52 (88) | 25 (83) | 27 (93) | 0.253 |
Dyslipidemia | 43 (73) | 21 (70) | 22 (76) | 0.620 |
Diabetes mellitus | 39 (66) | 17 (57) | 22 (76) | 0.124 |
Chronic kidney disease | 40 (68) | 20 (67) | 20 (69) | 0.853 |
Hemodialysis | 18 (30) | 10 (33) | 8 (28) | 0.639 |
Heart failure | 11 (19) | 5 (17) | 6 (21) | 0.698 |
Coronary artery disease | 44 (75) | 20 (67) | 24 (83) | 0.161 |
Cerebrovascular disease | 6 (10) | 4 (13) | 2 (7) | 0.422 |
Aspirin | 54 (91) | 26 (87) | 28 (96) | 0.179 |
P2Y12 Inhibitor | 44 (75) | 22 (73) | 22 (76) | 0.827 |
Cilostazol | 17 (29) | 9 (30) | 8 (28) | 0.841 |
Anti-coagulant | 8 (14) | 4 (13) | 4 (14) | 0.960 |
Statin | 30 (51) | 18 (60) | 12 (41) | 0.158 |